PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Research Article

Volume 5 Issue 5

Development and Validation of Novel ‘Polycystic Ovarian Syndrome’ Diagnostic Questionnaire for the Females of Reproductive Age

Khushi Patel, Rajvi Amin, Aanal Devani and Mustakim Mansuri*

October 30, 2024

DOI : 10.56831/PSMPH-05-176

View PDF

Abstract

Background: Polycystic ovarian syndrome (PCOS) is a complicated reproductive, metabolic, hormonal, and endocrine disorder that affects one in every five (20%) Indian women. As a result, detecting PCOS at a young age is critical. Currently, limited diagnostic tool exists to evaluate the risk and severity of PCOS in women of reproductive age. As a result, the focus of our research is on developing and evaluating the 'Novel PCOS diagnostic questionnaire', which will help both healthy people and PCOS patients determine their risk of getting PCOS and the severity of their illness respectively.

Method: Novel PCOS questionnaire was developed with questions related to demography, co-morbidity, symptoms, diet, and menstrual pattern. It was evaluated through theoretical validation, empirical validation, and reliability tests.

Results: The ‘Novel PCOS diagnostic questionnaire’ passes all the validation tests and it can be utilised further as diagnostic tool.

Conclusion: The preliminary development and validation of the Novel PCOS diagnostic questionnaire is highly relevant to be useful in the real-world. The validation of this questionnaire at a comprehensive spectrum is furtherly focussed.

Keywords: PCOS; validation study; questionnaire; risk and severity assessment

References

  1. El Hayek S., et al. “Poly Cystic Ovarian Syndrome: An Updated Overview”. Front Physiol 7 (2016): 124.
  2. Sonia Malik KJ., et al. “Management of Polycystic Ovary Syndrome in India”. Fertil Sci Res 1 (2014): 23-43.
  3. Louwers YV and Laven JSE. “Characteristics of polycystic ovary syndrome throughout life”. Ther Adv Reprod Health 14 (2020): 2633494120911038.
  4. Nidhi R., et al. “Prevalence of polycystic ovarian syndrome in Indian adolescents”. J Pediatr Adolesc Gynecol 24 (2011): 223-7.
  5. Sivayoganathan D., et al. “Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity”. Hum Fertil (Camb) 14 (2011): 261-5.
  6. Parker J., et al. “Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment”. Int J Environ Res Public Health 19 (2022): 1336.
  7. Ndefo UA, Eaton A and Green MR. “Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches”. P T 38 (2013): 336-55.
  8. Pedersen SD., et al. “Polycystic ovary syndrome: validated questionnaire for use in diagnosis”. Canadian family physician Medecin de famille canadien 53 (2007): 1042-1.
  9. Cronin L., et al. “Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)”. J Clin Endocrinol Metab 83 (1998): 1976-87.
  10. Hoeger KM, Dokras A and Piltonen T. “Update on PCOS: Consequences, Challenges, and Guiding Treatment”. J Clin Endocrinol Metab 106 (2021): e1071-e83.
  11. Sam S. “Obesity and Polycystic Ovary Syndrome”. Obes Manag 3 (2007): 69-73.
  12. Chen SF., et al. “Risk of bipolar disorder in patients with polycystic ovary syndrome: A nationwide population-based cohort study”. J Affect Disord 263 (2020): 458-62.
  13. Ee C., et al. “Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success”. BMC Endocrine Disorders 21 (2021): 234.
  14. Tasali E, Van Cauter E and Ehrmann DA. “Polycystic Ovary Syndrome and Obstructive Sleep Apnea”. Sleep Med Clin 3 (2008): 37-46.
  15. Hong X., et al. “Clinical Manifestations of Polycystic Ovary Syndrome and Associations with the Vaginal Microbiome: A Cross-Sectional Based Exploratory Study”. Front Endocrinol (Lausanne) 12 (2021): 662725.
  16. Mathur R., et al. “Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome”. Dig Dis Sci 55 (2010): 1085-9.
  17. Singla R., et al. “Thyroid disorders and polycystic ovary syndrome: An emerging relationship”. Indian J Endocrinol Metab 19 (2015): 25-9.
  18. Neubronner SA., et al. “Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study”. BMC Womens Health 21 (2021): 135.
  19. Yuan C., et al. “Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study”. J Biomed Res 30 (2016): 197-202.
  20. Bahman M., et al. “The Importance of Sleep Hygiene in Polycystic Ovary Syndrome from the View of Iranian Traditional Medicine and Modern Medicine”. Int J Prev Med 9 (2018): 87.
  21. Fernandez RC., et al. “Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies”. Nat Sci Sleep 10 (2018): 45-64.
  22. Baptiste CG., et al. “Insulin and hyperandrogenism in women with polycystic ovary syndrome”. J Steroid Biochem Mol Biol 122 (2010): 42-52.
  23. Pau CT, Keefe CC and Welt CK. “Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome”. Gynecol Endocrinol 29 (2013): 551-5.
  24. Aversa A., et al. “Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions”. Frontiers in Endocrinology 11 (2020): 516.
  25. Basu BR, Chowdhury O and Saha SK. “Possible Link Between Stress-related Factors and Altered Body Composition in Women with Polycystic Ovarian Syndrome”. J Hum Reprod Sci 11 (2018): 10-8.
  26. Daniilidis A and Dinas K. “Long term health consequences of polycystic ovarian syndrome: a review analysis”. Hippokratia 13 (2009): 90-2.
  27. Negriff S., et al. “The measurement of menstrual symptoms: factor structure of the menstrual symptom questionnaire in adolescent girls”. J Health Psychol 14 (2009): 899-908.
  28. Panidis D., et al. “Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome”. Eur J Endocrinol 168 (2013): 145-52.
  29. Spritzer PM, Barone CR and Oliveira FB. “Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management”. Curr Pharm Des 22 (2016): 5603-13.
  30. Teede H, Deeks A and Moran L. “Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan”. BMC Med 8 (2010): 41.
  31. Hajivandi L., et al. “Food habits in overweight and obese adolescent girls with Polycystic ovary syndrome (PCOS): a qualitative study in Iran”. BMC Pediatr 20 (2020): 277.
  32. Lazaridou S, Dinas K and Tziomalos K. “Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome”. Hormones (Athens) 16 (2017): 373-80.
  33. Nayak B S, Mallappa Bannigida D and Krishna Mohan S. “Diet and lifestyle of women with polycystic ovarian syndrome in South India”. International Journal of Clinical Biochemistry and Research 6 (2019): 29-31.
  34. Patten RK., et al. “Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis”. Front Physiol 11 (2020): 606.
  35. Sedighi S., et al. “Comparison of lifestyle in women with polycystic ovary syndrome and healthy women”. Glob J Health Sci 7 (2014): 228-34.
  36. Chakrabartty SN. “Best Split-Half and Maximum Reliability”. IOSR Journal of Research & Method in Education 3 (2013).
  37. Mohajan H. “Two Criteria for Good Measurements in Research: Validity and Reliability”. MPRA 17 (2017): 56-82.